Litcius/Paper detail

Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line

Praneet Sandhu, Nicholas J. Buchkovich

2020Journal of Virology38 citationsDOIOpen Access PDF

Abstract

Human cytomegalovirus (HCMV) is an opportunistic herpesvirus that is asymptomatic for healthy individuals but that can lead to severe pathology in patients with congenital infections and immunosuppressed patients. Thus, it is important to understand the modulation of the immune response by HCMV, which is understudied in the context of endogenous MHC class II regulation. Using Kasumi-3 cells as a myeloid progenitor cell model endogenously expressing MHC class II (HLA-DR), this study shows that HCMV decreases the expression of HLA-DR in infected cells by reducing the transcription of HLA-DR transcripts early during infection independently of the expression of previously implicated genes. This is an important finding, as it highlights a mechanism of immune evasion utilized by HCMV to decrease the expression of MHC class II in a relevant cell system that endogenously expresses the MHC class II complex.

Topics & Concepts

BiologyTransactivationMajor histocompatibility complexCD74VirologyCytomegalovirusGeneticsMyeloidHuman cytomegalovirusCell cultureClass (philosophy)MHC class ICell biologyGeneImmunologyHerpesviridaeVirusGene expressionViral diseaseComputer scienceArtificial intelligenceCytomegalovirus and herpesvirus researchHerpesvirus Infections and TreatmentsImmune Cell Function and Interaction